Valuation West Pharmaceutical Services, Inc.
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
After hours 03:00:00 | |||
| 358.24 USD | -1.16% |
|
329.10 | -8.14% |
| 01:18am | Abbott investigates two separate cyber incidents, says no operations affected | RE |
| 07-17 | US companies face rise in cyber attacks | RE |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 25,309 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 27.86% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 24,801 | 24,568 | 24,256 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 29.13% | -0.94% | -1.27% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 42.6x | 37.2x | 33.1x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 8.09x | 7.14x | 6.28x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.8x | 2.6x | 2.6x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.59x | 7.16x | 6.67x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 7.44x | 6.95x | 6.4x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 26.9x | 24.2x | 21.5x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 33.5x | 29.8x | 26.3x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 54x | 45.5x | 37.5x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.85% | 2.2% | 2.67% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.8774 | 0.9571 | 1.094 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.24% | 0.27% | 0.31% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.416 | 9.619 | 10.82 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.4% | 9.95% | 10.1% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,333 | 3,537 | 3,792 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 923.3 | 1,017 | 1,129 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 741.1 | 823.5 | 922 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 604.2 | 685.6 | 764.8 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -508.1 | -741.3 | -1,052 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 358.24 | 358.24 | 358.24 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,648 | - | - |
| Announcement Date | 2/17/22 A | 2/16/23 A | 2/15/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 43.07x | 7.53x | 27.18x | 0.24% | 25.31B | ||
| 25.6x | 3.46x | 13.25x | 2.51% | 175B | ||
| 18.96x | 3.32x | 11.67x | 3.56% | 106B | ||
| 17.13x | 0.19x | 12.1x | 0.77% | 59.91B | ||
| 31.6x | 7.68x | 20.07x | 1.27% | 51.95B | ||
| 39.85x | 3.15x | 10.75x | 2.41% | 43.58B | ||
| 39.41x | 1.42x | 12.54x | 0.25% | 33.65B | ||
| 31.86x | 5.68x | 18.11x | -.--% | 29.58B | ||
| 24.33x | 3.55x | 12.77x | 1.19% | 21.23B | ||
| 47.64x | 6.4x | 20.55x | 0.46% | 20.68B | ||
| Average | 31.94x | 4.24x | 15.90x | 1.26% | 56.77B | |
| Weighted average by Cap. | 27.78x | 3.74x | 14.34x | 1.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
















